Shockwave therapy shows promise for Parkinson's in tiny trial
NCT ID NCT06676995
First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times
Summary
This small study tested a non-invasive device called Transcranial Pulse Stimulation (TPS) in 14 people with Parkinson's disease. TPS uses sound wave pulses to stimulate the brain. Participants received 12 sessions over four weeks. Researchers checked if TPS safely improved movement, thinking, mood, and other symptoms compared to before treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcranial Pulse Stimulation (TPS) device
- What this could lead to
- If it works, this could point toward a non-invasive way to ease movement, thinking, and mood problems in Parkinson's disease.
- What could go wrong
- This was a very small, early study with only 14 people and no comparison group. Results may not apply to everyone, and the benefits might be small or temporary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
14 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosis of "probable" or "possible" Parkinson's Disease (PD), as defined by the current clinical criteria (52) or as confirmed by a co-investigator neurologist or confirmation via medical records or a letter from a patient's physician. 2. Age from 40 to 90 years old. 3. Disease stages 2 to 4 based on the UPDRS scale subdomain V (or Hoehn and Yahr scale). 4. Taking stable medications for Parkinson's Disease for at least 30 days. Exclusion Criteria: 1. Features suggestive of other causes of parkinsonism/Parkinson's-plus syndromes. 2. History of deep brain stimulation, brain ablation surgeries, or malignant mass brain lesions. 3. History of schizophrenia, bipolar illness, or alcohol/drug abuse within the past six months. 4. Need for rapid clinical response due to conditions such as initiation, psychosis, or suicidality. 5. Contraindications to transcranial brain stimulation (i.e., metal objects in the head, metal implanted brain medical devices, cortisone treatments within six weeks before the first stimulation session, central nervous system (CNS) thrombosis, etc). 6. Unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure, uncompensated pulmonary disease, or chronic obstructive pulmonary disease). 7. Contraindications to MRI according to Mass General Brigham screening in the Martinos Center (i.e., pacemaker, defibrillator or wires other than sternal wires, metallic foreign body in the eye, or drug infusion devices - if the models of these devices are not compatible with MRI). 8. Pregnancy. 9. Epilepsy or disorders that significantly increase the likelihood of seizures, including: (i) severe traumatic brain injury; (ii) congenital birth defects leading to seizures; (iii) brain tumor; (iv) metabolic disorders associated with seizures; (v) intracranial or subarachnoid hemorrhage; and (vi) non-lacunar strokes. 10. Bed- or wheelchair-bound patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Spaulding Rehabilitation Hospital
Cambridge, Massachusetts, 02138, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a driving simulator reveal hidden driving risks in Parkinson's and MS?
- Could a breath test reveal Parkinson's risk?
- Can a gentle brain current help Parkinson's patients learn movements again?
- Gene mutation may amplify cognitive risks of brain stimulation in Parkinson's
- Can simple calf raises rewire muscle energy in Parkinson's?
- Which balance test best predicts falls in Parkinson's? a head-to-head comparison